Laser therapy with semiconductor laser (wavelength 890 nm) was performed in 41 patients with II^a - III^ast. breast cancer. LLLT was used before surgery and in postoperative period during 2 years. LLLT decreased postoperative complications by 15.3% and decreased duration of lymphorrhea. 5 years survival in patients with II^ast. breast cancer treated by LLLT was 100%, in control group--85.71%. In patients with III^ast. breast cancer treated by LLLT survival was 94.44%, in control group--78.94%. 91.3% of patients with II^ast. treated by LLLT had not recurrences in 5 year period, in the controls they were in about 77.7%. 82.35% of patients with III^ast. treated by laser therapy had no recurrences in 5 year period, in control group--60%.

Date Published: 8 January 1996
PDF: 9 pages
Proc. SPIE 2728, CIS Selected Papers: Laser Use in Oncology, (8 January 1996); doi: 10.1117/12.229474

Published in SPIE Proceedings Vol. 2728:
CIS Selected Papers: Laser Use in Oncology
Andrei V. Ivanov; Mishik A. Kazaryan, Editor(s)